The Comparative Effectiveness of First-Line Tumor Necrosis Factor Inhibitor (TNFi) Compared with Non-TNFi Agents in Patients with Rheumatoid Arthritis: Results from the Corrona Registry

被引：0
|
作者：
Pappas, Dimitrios A. [1 ]
St John, Gregory [2 ]
Etzel, Carol J. [1 ]
Fiore, Stefano [3 ]
Blachley, Taylor [1 ]
Kimura, Toshio [2 ]
Punekar, Rajeshwari [3 ]
Emeanuru, Kelechi [1 ]
Boklage, Susan [2 ]
Kremer, Joel [1 ,4 ,5 ]
机构：
[1] Corrona LLC, Waltham, MA USA
[2] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[3] Sanofi, Bridgewater, NJ USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Ctr Rheumatol, Albany, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2877
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan
    Chastek, Benjamin
    Curtis, Jeffrey R.
    Becker, Laura K.
    Joseph, George J.
    Chen, Chieh-I
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Patients with Rheumatoid Arthritis: Data from the ACR's RISE Registry
    Gianfrancesco, Milena
    Li, Jing
    Ja, Clairissa
    Seet, Andrea
    Schmajuk, Gabriela
    Yazdany, Jinoos
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1193 - 1194
  • [3] RISK OF HEART FAILURE FOLLOWING EXPOSURE TO NON-TNFI COMPARED TO TNFI BIOLOGICS IN US PATIENTS WITH RHEUMATOID ARTHRITIS
    Jensen, Thomas Bo
    Tsao, Nicole
    Pawar, Ajinkya
    Desai, Rishi J.
    Kim, Seoyoung
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1392 - 1392
  • [4] Risk of heart failure following exposure to non-TNFi compared to TNFi biologics in US patients with rheumatoid arthritis
    Jensen, Thomas Bo
    Tsao, Nicole
    Pawar, Ajinkya
    Desai, Rishi
    Kim, Seoyoung
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 421 - 421
  • [5] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Leslie R. Harrold
    George W. Reed
    Daniel H. Solomon
    Jeffrey R. Curtis
    Mei Liu
    Jeffrey D. Greenberg
    Joel M. Kremer
    Arthritis Research & Therapy, 18
  • [6] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Harrold, Leslie R.
    Reed, George W.
    Solomon, Daniel H.
    Curtis, Jeffrey R.
    Liu, Mei
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [7] COMPARATIVE EFFECTIVENESS OF TNFI AND TOFACITINIB MONOTHERAPY IN CLINICAL PRACTICE: RESULTS FROM CORRONA REGISTRY
    Reed, G. W.
    Gerber, R. A.
    Shan, Y.
    Takiya, L.
    Dandreo, K. J.
    Gruben, D.
    Kremer, J. M.
    Wallenstein, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 228 - 228
  • [8] REAL-WORLD EFFECTIVENESS OF TNFI VERSUS NON-TNFI BIOLOGICS ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE ACR'S RISE REGISTRY
    Gianfrancesco, M.
    Li, J.
    Evans, M.
    Petersen, M.
    Schmajuk, G.
    Yazdany, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 65 - 66
  • [9] COMPARATIVE EFFECTIVENESS OF ABATACEPT VERSUS TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE CCP plus IN THE UNITED STATES CORRONA REGISTRY
    Harrold, L.
    Litman, H.
    Connolly, S.
    Alemao, E.
    Price, K.
    Kelly, S.
    Rebell, S.
    Hua, W.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1192 - 1192
  • [10] TNFI AND TOFACITINIB MONOTHERAPY AND COMPARATIVE EFFECTIVENESS IN CLINICAL PRACTICE: RESULTS FROM CORRONA REGISTRY
    Reed, G. W.
    Gerber, R. A.
    Shan, Y.
    Takiya, L.
    Dandreo, K. J.
    Gruben, D.
    Kremer, J. M.
    Wallenstein, G. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 60 - 60
12345